Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of GRN163L With Paclitaxel and Bevacizumab to Treat Patients With Locally Recurrent Or Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00732056
Recruitment Status : Completed
First Posted : August 11, 2008
Last Update Posted : December 24, 2015
Sponsor:
Information provided by (Responsible Party):
Geron Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2011
Actual Study Completion Date : March 2012